ArticleJapanese journal of radiology2026
Clinical factors affecting colonic iodine-131 distribution after radioactive iodine therapy for thyroid cancer.
Article in Japanese journal of radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeRadioactive iodine therapy (RAIT) is used to treat patients with thyroid cancer at high risk of recurrence or those with distant metastases. Small amounts of iodine-131 (I-131) are excreted in the stool after RAIT. Thyroid hormone withdrawal (THW) before RAIT can cause constipation, increasing radiation exposure to the colon. Although measuring colonic radiation using I-131 dosimetry would be challenging, colonic radiation dose can be estimated using I-131 whole-body scintigraphy post-RAIT. Therefore, we aimed to determine the clinical risk factors, including THW, associated with colonic distribution on I-131 scintigraphy post-RAIT. MATERIALS AND
methodsWe analyzed 251 patients who received 530 RAITs, categorized into two groups based on the preparation method. We compared the relationship between clinical risk factors (including preparation method) and colonic I-131 distribution 3 d post-RAIT. In addition, we compared the frequency and degree of colonic I-131 distribution between patients who received RAITs with stimulant laxatives and those who received RAITs with osmotic laxatives. Four subgroup analyses were conducted based on the preparation method and defecation frequency.
resultsWe performed 253 RAITs (47.7%) using recombinant human thyrotropin, while the remaining 277 RAITs (52.3%) were performed using THW. In the multivariate analysis, THW, higher RAIT dose (≥ 3.7 GBq), and fewer defecation frequencies (≤ 2 times) were significantly associated with a higher frequency of colonic I-131 distribution (p = 0.0206, 0.0020, and 0.0006, respectively). Of the patients treated using THW RAITs, which relieved constipation, those treated with RAITs with stimulant laxatives had significantly lower colonic I-131 distribution than did those treated with RAITs with osmotic laxatives (p = 0.0378).
conclusionTHW, high-dose RAIT, and defecation frequency were significantly associated with colonic I-131 distribution. Pre-treatment strategies, such as the use of stimulant laxatives should be considered to reduce colonic radiation exposure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.